Although it was prescribed off-label previously for weight loss, this led to medication shortages
The MariTide Phase 2 data presented in November 2024 were highly significant: MariTide demonstrated robust weight loss at 52 weeks with no plateau meaning continued weight loss trajectory at the end of the study period, unlike semaglutide and tirzepatide which show plateau effects and significant improvements in cardiometabolic parameters
The trials indicated that all doses of tirzepatide resulted in greater weight loss and enhanced glycemic control in comparison to placebo
You might consider preparing fresh solutions more frequently or calculating a slightly higher initial concentration to compensate for expected degradation over time
GLP-1 for Weight Loss: How It Works GLP-1 for weight loss medications work with your body, not against it
Jankowski J, Floege J, Fliser D, Bohm M, Marx N